Scynexis (SCYX) Other financing activities (2013 - 2026)
Scynexis' (SCYX) quarterly Other financing activities came in at $17000.0 in Q1 2026, down 34.62% on a YoY basis from $26000.0 in Q1 2025, and down 32.0% quarter-over-quarter from $25000.0 in Q3 2025.
Powered by 
Analysis
Scynexis (SCYX) Other financing activities (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has reported Other financing activities for 14 consecutive years, with $17000.0 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities fell 34.62% year-over-year to $17000.0; the trailing twelve-month figure through Jun 2026 stood at $42000.0 (down 26.32% YoY), and the FY2025 full-year result was $51000.0, down 8.93% from the prior year.
- Other financing activities fell to $17000.0 in Q1 2026 per SCYX's latest filing, from $25000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $38000.0 in Q3 2023 and bottomed at $4000.0 in Q1 2023.
- Historically, Other financing activities has averaged $20444.4 across 5 years, with a median of $25000.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Other financing activities slumped 60.0% in 2023, then surged 525.0% in 2024.
- Over 5 years, Other financing activities stood at $8000.0 in 2022, then jumped by 375.0% to $38000.0 in 2023, then declined by 18.42% to $31000.0 in 2024, then slipped by 19.35% to $25000.0 in 2025, then plunged by 32.0% to $17000.0 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $17000.0, $25000.0, and $26000.0 for Q1 2026, Q3 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Scynexis | 52.73 Mn | -61.96 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 26,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Sep 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Sep 30, 2020 | 10,000.00 |
| Mar 31, 2020 | 18,000.00 |
| Sep 30, 2019 | 28,000.00 |
| Jun 30, 2019 | 1,000.00 |
| Mar 31, 2019 | 20,000.00 |
| Sep 30, 2018 | 19,000.00 |
| Mar 31, 2018 | 20,000.00 |
| Dec 31, 2017 | -1,000.00 |